Connect Biopharma to Present at the San Francisco Biotech Showcase in January
SAN DIEGO and TAICANG, SUZHOU, China, Dec. 19, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
SAN DIEGO and TAICANG, SUZHOU, China, Dec. 19, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Regulatory submission for the expanded indication is supported by data from two recently completed 4-week…
Tislelizumab supplied by BeiGene as part of ImmixBio’s Clinical Trial and Supply Agreement with BeiGene…
Appointment brings more than 20 years of life sciences finance leadership experience to the CFO…
Mr. Lee brings almost 15 years of experience in strategy, M&A and partnering on more…
Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala Capital and…
In initial ABI-H3733 cohort of 50 mg in 28-day Phase 1b study, six of eight…
–Reduced TGF-β2, but not TGF-β1 nor TGF-β3, is associated with improved OS. AGOURA HILLS, Calif.,…
BOTHELL, Wash., Dec. 19, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces highly…
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
NEW HAVEN, Conn., Dec. 19, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the…
53% mean exon skipping and <1% (BLQ) mean dystrophin expression six weeks after initiating biweekly…
100% Survival Rate in Anthrax-infected Rabbits Treated with Omadacycline Total Revenue Recognition to Paratek of…
TORONTO, Dec. 19, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…
Glofitamab is an investigational T-cell engaging bispecific antibody targeting CD20 and CD3 in development for…
Pivotal trial will evaluate efficacy and safety of BXCL501 in Alzheimer’s patients in nursing homes…
Pfizer will now lead all development and commercialization activities in Mainland China, Hong Kong, Macau,…
REHOVOT, Israel and HOBOKEN, N.J., Dec. 19, 2022 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA;…
Results from Planned Interim Analysis of First 50 Percent of Participants Expected Second Quarter 2023…
SAN FRANCISCO, Dec. 19, 2022 (GLOBE NEWSWIRE) — With just a few days until Christmas,…